Literature DB >> 17394186

The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis.

Zbigniew M Szczepiorkowski1, Beth H Shaz, Nicholas Bandarenko, Jeffrey L Winters.   

Abstract

The American Society for Apheresis (ASFA) Apheresis Applications Committee is responsible for a review and categorization of indications for therapeutic apheresis. The results of the review process were previously published in 1986, 1993, and 2000 as the ASFA Special Issues. The ASFA categories consist of categories I through IV, and category P (pending). This article describes the novel methodology, based on structured systematic review of the published literature, used to assign categories for indications for therapeutic apheresis. This is the first time each entity is presented as a fact sheet, which summarizes the evidence for the use of therapeutic apheresis. A detailed description of the fact sheet format and the individual fact sheets for categories I through III and category P are presented in the main article of this Special Issue. The diseases assigned to category IV are discussed in a separate article in this issue. Information on how the Apheresis Applications Committee proposes to include new diseases for category assignment is also provided.

Mesh:

Year:  2007        PMID: 17394186     DOI: 10.1002/jca.20134

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  4 in total

1.  Therapeutic Plasma Exchange in Patients with Neurologic Disorders: Review of 63 Cases.

Authors:  Anil Tombak; Mehmet Ali Uçar; Aydan Akdeniz; Arda Yilmaz; Hakan Kaleagası; Mehmet Ali Sungur; Eyup Naci Tiftik
Journal:  Indian J Hematol Blood Transfus       Date:  2016-02-22       Impact factor: 0.900

2.  Therapeutic plasma apheresis as a treatment for 35 severely ill children and adolescents with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections.

Authors:  M Elizabeth Latimer; Nathan L'Etoile; Jakob Seidlitz; Susan E Swedo
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-02-06       Impact factor: 2.576

3.  A comparison among three different apheretic techniques for treatment of hyperbilirubinemia.

Authors:  Davide Viggiano; Emanuela de Pascale; Gaia Marinelli; Corrado Pluvio
Journal:  J Artif Organs       Date:  2017-09-08       Impact factor: 1.731

4.  Use of plasmapheresis in managing the diagnostic dilemma of symptomatic hypertriglyceridemia.

Authors:  Nigel Gordon Maher; Hariharan Ramaswamykanive
Journal:  Case Rep Gastrointest Med       Date:  2012-12-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.